Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia
Elizabeth T. Rogawski McQuade, Kristin A. Guertin, Lea Becker, et al.
JAMA Network Open (2021) Vol. 4, Iss. 2, pp. e2035234-e2035234
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity
Sandy Joung, Joseph E. Ebinger, Nancy Sun, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2227241-e2227241
Open Access | Times Cited: 44
Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022
Ryan E. Wiegand, Yangyang Deng, Xiaoyi Deng, et al.
The Lancet Regional Health - Americas (2022) Vol. 18, pp. 100403-100403
Open Access | Times Cited: 44
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery
Maddalena Peghin, Maria De Martino, Martina Fabris, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 11
Open Access | Times Cited: 48
Social Vulnerability and Rurality Associated With Higher Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection–Induced Seroprevalence: A Nationwide Blood Donor Study—United States, July 2020–June 2021
Zheng Li, Brian Lewis, Kevin Berney, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e133-e143
Open Access | Times Cited: 31
SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis
Mobin Azami, Yousef Moradi, Asra Moradkhani, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records
Deborah S. Hasin, David S. Fink, Mark Olfson, et al.
Drug and Alcohol Dependence (2022) Vol. 234, pp. 109383-109383
Open Access | Times Cited: 21
A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States
Rebecca Levorson, Erica Christian, Brett Hunter, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0259823-e0259823
Open Access | Times Cited: 22
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
Abbas Hoballah, Rana El Haidari, Ghina Siblany, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Colorectal Cancer: In the Pursuit of Health Equity
Laura W. Musselwhite, Folasade P. May, Mohamed E. Salem, et al.
American Society of Clinical Oncology Educational Book (2021), Iss. 41, pp. 108-117
Open Access | Times Cited: 16
Association between COVID-19 risk-mitigation behaviors and specific mental disorders in youth
Kevin P. Conway, Kriti Bhardwaj, Emmanuella Michel, et al.
Child and Adolescent Psychiatry and Mental Health (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Prevalence of Anti-SARS-CoV-2 Antibodies in Poznań, Poland, after the First Wave of the COVID-19 Pandemic
Dagny Lorent, Rafał Nowak, Carolina Roxo, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 541-541
Open Access | Times Cited: 14
Seropositivity of COVID-19 among asymptomatic healthcare workers: A multi-site prospective cohort study from Northern Virginia, United States
Abdulla A. Damluji, Siqi Wei, Scott A. Bruce, et al.
The Lancet Regional Health - Americas (2021) Vol. 2, pp. 100030-100030
Open Access | Times Cited: 14
Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach
Erin Williams, Alexander Kizhner, Valerie S. Stark, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Limited impact of contact tracing in a University setting for COVID-19 due to asymptomatic transmission and social distancing
Daniel Stocks, Emily Nixon, Adam Trickey, et al.
Epidemics (2023) Vol. 45, pp. 100716-100716
Open Access | Times Cited: 5
Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020
Cesar A. Lopez, Clark H. Cunningham, Sierra Pugh, et al.
mSphere (2022) Vol. 7, Iss. 3
Open Access | Times Cited: 8
The effects of 105 biological, socioeconomic, behavioral, and environmental factors on the risk of SARS-CoV-2 infection and a severe course of COVID-19: a prospective, explorative cohort study
Jaroslav Flegr, Pavel Flegr, Lenka Příplatová
Biology Methods and Protocols (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 8
COVID-19: seroprevalence and adherence to preventive measures in Arkhangelsk, Northwest Russia
E. A. Kriеger, Ekaterina Sharashova, Alexander V. Kudryavtsev, et al.
Infectious Diseases (2023) Vol. 55, Iss. 5, pp. 316-327
Open Access | Times Cited: 4
Prevalence of anti-SARS-CoV-2 antibodies in Poznań, Poland, after the first wave of the COVID-19 pandemic
Dagny Lorent, Rafał Nowak, Carolina Roxo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 11
A study of the evolution of the third COVID‐19 pandemic wave in the Athens metropolitan area, Greece, through two cross‐sectional seroepidemiological surveys: March, June 2021
Helena C. Maltezou, Bettina Krumbholz, Maria Mavrouli, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1465-1472
Open Access | Times Cited: 11
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology
Lucy Ochola, Paul Ogongo, Samuel Mungai, et al.
Clinics in Laboratory Medicine (2021) Vol. 42, Iss. 1, pp. 31-56
Open Access | Times Cited: 10
Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period
Cesar A. Lopez, Clark H. Cunningham, Sierra Pugh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Predictors of anti-SARS-CoV-2 seropositivity: An Egyptian population-based study
Engy Mohamed El‐Ghitany, Ayat Ashour, Azza Galal Farghaly, et al.
Infectious Medicine (2022) Vol. 1, Iss. 2, pp. 113-123
Open Access | Times Cited: 6
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020–March 2021
Anna R. Giuliano, Shari Pilon‐Thomas, Michael J. Schell, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 3, pp. 556-563
Open Access | Times Cited: 5
The SARS-CoV-2 Infection Among Students in the University of Porto: A Cross-Sectional Study
Paula Meireles, Joana Pinto Costa, Maria João da Costa Novais, et al.
International Journal of Public Health (2022) Vol. 67
Open Access | Times Cited: 5
Use of Extended Reality in Medicine During the Covid-19 Pandemic
Samuel Sherng Young Wang
Intelligent systems reference library (2022), pp. 1-14
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top